HemeUniverse logo

HemeUniverse

Hematology drawn as stories you can remember.

Trial breakdowns now and sketch lessons on the way, for students, residents and fellows.

Follow along

Instagram@hemeuniverse TikTok@hemeuniverse

Recent trial breakdown

MIDAS: response-adapted treatment in newly diagnosed, transplant-eligible myeloma Read the breakdown on Instagram

Who makes it

Feras Al-Moussally, MD, a board-certified internist now training in hematology and oncology, is building HemeUniverse the same way he built OncUniverse. Each sketch will tell the story of a blood disorder, benign or malignant, with characters you can still picture when it shows up on an exam or on rounds. The first lessons are still in the works. His hematology research includes a multicenter cohort study of pregnancy outcomes in women with thalassemia trait (Anemia, 2025) and a co-first-author case report on POEMS syndrome (Cureus, 2026), and he is a member of the American Society of Hematology.

Sister brands

OncUniverseCancer medicine drawn as sketch lessons EthicsUniverseMedical ethics questions for USMLE prep